We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.7%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$20.1B
AUM Growth
+$2.18B
(+12%)
Cap. Flow
+$1.44B
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
1,701
New
303
Increased
536
Reduced
489
Closed
373
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$260M |
| 2 |
CVS Health
CVS
|
+$204M |
| 3 |
Accenture
ACN
|
+$201M |
| 4 |
Johnson & Johnson
JNJ
|
+$188M |
| 5 |
NVIDIA
NVDA
|
+$168M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$171M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$158M |
| 3 |
CME Group
CME
|
+$128M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$126M |
| 5 |
Apple
AAPL
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.25% |
| 2 | Healthcare | 16.53% |
| 3 | Consumer Discretionary | 13.4% |
| 4 | Industrials | 11.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Denali Therapeutics
DNLI
$4.05B
| $224K | ﹤0.01% |
9,705
-11,782
| -55% | -$324K |
|
1302
Hilton Grand Vacations
HGV
$3.46B
| $220K | ﹤0.01% |
+4,946
| New | +$224K |
|
|
NVMI
1303
Nova
NVMI
$13.2B
| $217K | ﹤0.01% |
2,076
-2,622
| -56% | -$245K |
|
|
APEN
1304
DELISTED
Apollo Endosurgery, Inc.
APEN
| $216K | ﹤0.01% |
+21,770
| New | +$216K |
|
1305
Equifax
EFX
$21.3B
| $213K | ﹤0.01% |
+1,052
| New | +$219K |
|
|
AJRD
1306
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $213K | ﹤0.01% |
+3,787
| New | +$212K |
|
1307
LKQ Corp
LKQ
$6.23B
| $211K | ﹤0.01% |
3,723
-15,379
| -81% | -$867K |
|
1308
Federated Hermes
FHI
$4.66B
| $209K | ﹤0.01% |
5,209
-22,506
| -81% | -$883K |
|
1309
Nabors Industries
NBR
$1.34B
| $207K | ﹤0.01% |
1,696
-43,309
| -96% | -$6.56M |
|
1310
Viridian Therapeutics
VRDN
$2.53B
| $207K | ﹤0.01% |
+8,119
| New | +$260K |
|
|
ERF
1311
DELISTED
Enerplus Corporation
ERF
| $204K | ﹤0.01% |
14,175
-66,966
| -83% | -$1.08M |
|
1312
Grupo Aeroportuario del Pacifico
PAC
$12.4B
| $201K | ﹤0.01% |
+1,032
| New | +$187K |
|
1313
Grid Dynamics Holdings
GDYN
$634M
| $194K | ﹤0.01% |
16,914
-51,204
| -75% | -$601K |
|
1314
Riot Platforms
RIOT
$7.56B
| $194K | ﹤0.01% |
+19,385
| New | +$126K |
|
1315
Ecopetrol
EC
$35B
| $189K | ﹤0.01% |
17,902
-149,978
| -89% | -$1.63M |
|
|
NEX
1316
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $178K | ﹤0.01% |
+22,360
| New | +$200K |
|
1317
Navitas Semiconductor
NVTS
$3.68B
| $178K | ﹤0.01% |
+24,312
| New | +$136K |
|
|
LUCK
1318
Lucky Strike Entertainment
LUCK
$941M
| $177K | ﹤0.01% |
+10,438
| New | +$155K |
|
1319
Theravance Biopharma
TBPH
$878M
| $173K | ﹤0.01% |
15,936
-29,877
| -65% | -$316K |
|
|
SILV
1320
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $166K | ﹤0.01% |
+23,295
| New | +$143K |
|
|
JBGS
1321
JBG SMITH
JBGS
$691M
| $166K | ﹤0.01% |
+11,018
| New | +$195K |
|
|
ITOS
1322
DELISTED
iTeos Therapeutics
ITOS
| $163K | ﹤0.01% |
11,952
-43,739
| -79% | -$784K |
|
1323
Banc of California
BANC
$3.13B
| $145K | ﹤0.01% |
+11,573
| New | +$187K |
|
1324
Affirm
AFRM
$25.3B
| $134K | ﹤0.01% |
+11,916
| New | +$150K |
|
1325
ADT
ADT
$5.33B
| $128K | ﹤0.01% |
17,729
-187,905
| -91% | -$1.53M |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, Voloridge Investment Management held 1,701 positions worth $20.1B, up 12% from $17.9B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Voloridge Investment Management deployed $1.44B of net new capital in Q1 2023, opening 303 new positions and adding to 536 existing holdings. Its largest new stake was NVIDIA: 7,755,630 shares worth $215M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $158M trimmed.
- Voloridge Investment Management's largest Q1 2023 buy was NVIDIA: 7,755,630 shares worth $215M.
- Voloridge Investment Management added most to UnitedHealth in Q1 2023, an estimated $260M increase.
- Voloridge Investment Management's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $158M.
- Voloridge Investment Management fully exited Meta Platforms (Facebook) in Q1 2023, selling an estimated $171M.
- Voloridge Investment Management's ten largest holdings make up 9.1% of its $20.1B portfolio in Q1 2023.
- Voloridge Investment Management opened 303 new positions and closed 373 in Q1 2023.
- Voloridge Investment Management's portfolio value rose 12% quarter-over-quarter to $20.1B.
Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.